Fundamental Data for ACUS

ACUSPHERE(OTC:ACUS)

Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.

# Employees: 118

Address: 500 Arsenal Street,Watertown,MA,USA

Phone: 617 648-8800

Fax: 617 926-4750

Website: www.acusphere.com

Email: ir@acusphere.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Sherri C. Oberg (Presi.; C.E.O.; Dir.)

Lawrence A. Gyenes (Sr. V.P.; C.F.O.; Princ. Acctg. Off.)

Frank Baldino Jr. (Dir.)

Garen Bohlin (Dir.)

Sandra L. Fenwick (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 12/31/2008

Next Earnings Date(Expected): 11/27/2009

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.01)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 0

Shares Performance

Period	ACUS	Compare to S&P
YTD	17.14 %	-3.06 %
4 Weeks	-3.53 %	-8.42 %
12 Weeks	-21.91 %	-27.28 %

Shares Information

Analyst Coverage: N

Avg Volume: 92240

Shares Outstanding: 49M

Market Cap: $0.00B

52 Week High: $0.75

52 Week Low: $0.02

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 ACUS split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: 13.04 %

EPS Growth in Last Year: 25.93 %

Sales Growth in Last Quarter: 143.07 %

Sales Growth in Last Quarter: 23.54 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010